Download
41999_2024_Article_969.pdf 2,20MB
WeightNameValue
1000 Titel
  • Invasive meningococcal disease in older adults: current perspectives and call for action
1000 Autor/in
  1. Weil Olivier, Catherine |
  2. TAHA, Muhamed-Kheir |
  3. Leng, Sean |
  4. Dinleyici, Ener Cagri |
  5. Bonanni, Paolo |
  6. Moya, Elena |
  7. Leischker, Andreas Herbert |
  8. Yezli, Saber |
1000 Verlag
  • Springer International Publishing
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-05-06
1000 Erschienen in
1000 Quellenangabe
  • 15(3):729-741
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s41999-024-00969-0 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11329530/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>Invasive meningococcal disease (IMD) is a devastating condition. While most attention is directed towards disease in children and adolescents, IMD poses an important cause of morbidity and mortality in adults ≥60 years. While immunization is a critical component of healthy ageing strategies, meningococcal immunization is not routinely offered to older adults. The aim of this review was to summarize clinical and epidemiological aspects of IMD and available immunization strategies, with a particular focus on disease in older individuals, to emphasize the importance of this rather neglected area.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>An expert working group was established to evaluate clinical and epidemiological data to raise awareness of IMD in older individuals, and develop suggestions to improve the existing burden.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Routine child and adolescent meningococcal immunization has substantially reduced IMD in these targeted populations. Consequently, prevalence and proportion of IMD among those ≥60 years, mostly unvaccinated, is increasing in developed countries (accounting for up to 25% of cases). IMD-related mortality is highest in this age-group, with substantial sequelae in survivors. IMD due to serogroups W and Y is more prevalent among older adults, often with atypical clinical features (pneumonia, gastrointestinal presentations) which may delay timely treatment.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>IMD in older adults remains overlooked and greater awareness is required at clinical and societal levels. We encourage clinicians and immunization policy makers to reconsider IMD, with a call for action to remedy existing inequity in older adult access to protective meningococcal immunization.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Invasive meningococcal disease
lokal Immunization
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Increased risk
lokal Meningococcal Vaccines/therapeutic use [MeSH]
lokal Humans [MeSH]
lokal Vaccine equity
lokal Middle Aged [MeSH]
lokal Meningococcal Infections/prevention
lokal Neisseria meningitidis [MeSH]
lokal Male [MeSH]
lokal Older adults
lokal Meningococcal Infections/epidemiology [MeSH]
lokal Review
lokal Vaccination [MeSH]
lokal Prevalence [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-5271-1945|https://orcid.org/0000-0002-0716-3174|https://orcid.org/0000-0002-2690-8055|https://orcid.org/0000-0002-0339-0134|https://orcid.org/0000-0003-2875-3744|https://frl.publisso.de/adhoc/uri/TW95YSwgRWxlbmE=|https://orcid.org/0000-0001-6390-2640|https://orcid.org/0000-0002-3380-7092
1000 Hinweis
  • DeepGreen-ID: 4783bd8071274b47806c28fbb6be14bd ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Sanofi |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Sanofi |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6523218.rdf
1000 Erstellt am 2025-07-06T20:06:16.139+0200
1000 Erstellt von 322
1000 beschreibt frl:6523218
1000 Zuletzt bearbeitet 2025-07-29T21:01:10.067+0200
1000 Objekt bearb. Tue Jul 29 21:01:10 CEST 2025
1000 Vgl. frl:6523218
1000 Oai Id
  1. oai:frl.publisso.de:frl:6523218 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source